Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LIN-28B Activators

Activation of LIN-28B, a crucial RNA-binding protein, involves intricate mechanisms that impact its expression and functions within the cell. Several chemicals have been identified that can modulate LIN-28B activity, shedding light on potential strategies for its activation. Retinoic acid can effectively activate LIN-28B expression by binding to retinoic acid receptors, subsequently promoting LIN-28B transcription. This activation is particularly relevant in the context of embryonic development and cell differentiation. 5-Azacytidine offers another indirect route to activate LIN-28B by functioning as a DNA demethylating agent. This compound reduces DNA methylation at the LIN-28B promoter region, enhancing the accessibility of regulatory elements and facilitating LIN-28B expression. Trichostatin A, a histone deacetylase inhibitor, promotes LIN-28B expression by increasing histone acetylation at the LIN-28B gene locus. DMSO (Dimethyl Sulfoxide) acts as a solvent for certain LIN-28B-activating compounds, indirectly inducing LIN-28B expression. Sodium butyrate, another histone deacetylase inhibitor, indirectly activates LIN-28B expression by augmenting histone acetylation at its promoter.

Valproic acid, also an HDAC inhibitor, promotes LIN-28B expression by enhancing histone acetylation, contributing to the activation of this RNA-binding protein. 5-Aza-2'-deoxycytidine serves as a demethylating agent, reducing DNA methylation at the LIN-28B promoter and activating LIN-28B expression. TSA (Trichostatin A), a histone deacetylase inhibitor, increases LIN-28B expression by enhancing histone acetylation at the LIN-28B gene locus. Vorinostat, an HDAC inhibitor, can also promote LIN-28B expression by elevating histone acetylation levels. Decitabine, another demethylating agent, activates LIN-28B by reducing DNA methylation at its promoter region. Butyric acid indirectly activates LIN-28B expression by serving as a precursor to histone acetylation within the cell. Valproate, a histone deacetylase inhibitor, enhances LIN-28B expression by increasing histone acetylation levels at the LIN-28B gene locus.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor that can promote LIN-28B expression by increasing histone acetylation at the LIN-28B gene locus.

Dimethyl Sulfoxide (DMSO)

67-68-5sc-202581
sc-202581A
sc-202581B
100 ml
500 ml
4 L
$31.00
$117.00
$918.00
136
(6)

DMSO can induce LIN-28B expression by acting as a solvent for certain LIN-28B-activating compounds.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate, a histone deacetylase inhibitor, can indirectly activate LIN-28B expression by increasing histone acetylation at its promoter.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Valproic acid is another histone deacetylase inhibitor that can promote LIN-28B expression by enhancing histone acetylation.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

This demethylating agent can activate LIN-28B by reducing DNA methylation at the LIN-28B promoter.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Vorinostat, an HDAC inhibitor, can promote LIN-28B expression by increasing histone acetylation levels.

Butyric acid

107-92-6sc-214640
sc-214640A
1 kg
10 kg
$64.00
$177.00
(0)

Butyric acid can indirectly activate LIN-28B expression by serving as a precursor to histone acetylation in the cell.